Physician profile
Jeb Williams
NPI 1114311198
$17,843.38
in general payments reported to CMS, 2019-2025
13 companies · $405 in 2025
The $405 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $8,940 · 2021: $7,793 · 2022: $155 · 2023: $238 · 2024: $177 · 2025: $405.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $821.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $820.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $15,000.00 | 2020-2021 | |
| Alon Medical Technology | $1,260.29 | 2020 | |
| Zimmer Biomet Holdings, INC. | $500.89 | 2020-2024 | Gel-One Cross-Linked Hyaluronate, Comprehensive Shoulder System, Subchondroplasty Knee Kit |
| Orthalign INC | $351.65 | 2023-2025 | Orthalign Plus |
| Depuy Synthes Sales INC. | $232.73 | 2020-2022 | |
| Sanara Medtech INC. | $150.19 | 2025 | Celleraterx |
| Stryker Corporation | $124.73 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $66.42 | 2022 | |
| Innovation Technologies INC | $55.77 | 2025 | Irrisept |
| Endo Pharmaceuticals INC. | $48.35 | 2022-2024 | Xiaflex |
| Bioventus LLC | $23.44 | 2025 | Xcell |
| Endo USA, INC. | $17.92 | 2025 | Xiaflex |
| Wright Medical Technology, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeb Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.